aTyr Pharma | LIFE - Sales Revenues


aTyr Pharma reported $2.29M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Ardelyx USD 94.47M 30.74M Mar/2026
aTyr Pharma USD 2.29M 107.78M Mar/2026
Biogen USD 2.74B 490M Jun/2026
Bristol-Myers Squibb USD 12.97B 1.48B Jun/2026
Cipla INR 71.19B 5.78B Jun/2026
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 6.35M 60.98M Mar/2026
CSL USD 8.33B 4.79B Dec/2025
Curis USD 1.14M 1.41M Dec/2025
GlaxoSmithKline GBP 8.41B 781M Jun/2026
Grifols EUR 2B 306.7M Mar/2026
Lakefront Biotherapeutics EUR 6.5M 894.32M Mar/2026
Novartis USD 14.41B 1.3B Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
United Therapeutics USD 783.3M 1.8M Jun/2026